Answers are grounded in this paper and cite their sources.
Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal failure in patients with type 2 diabetes mellitus (T2DM). Albuminuria is an early marker of renal damage, while hyperuricemia has been increasingly recognized as a possible risk factor for kidney disease progression. Objective: To evaluate the relationship between elevated serum uric acid levels and the presence and severity of albuminuria in patients with type 2 diabetes. Methods: A retrospective, hospital-based study was conducted at Ziauddin University Hospital, Clifton Campus during June 2024 till November 2024. A total of 400 patients with T2DM were included using non-probability purposive sampling. Inclusion criteria were age >18 years, confirmed T2DM, serum uric acid ≥7 mg/dL, and spot urine albumin–creatinine ratio (UACR) >30 mg/g. Patients with UTI, stage 5 CKD, autoimmune disease, malignancy, or on medications affecting uric acid levels were excluded. Results: The mean serum uric acid level was 7.8 ± 0.6 mg/dL, and the mean UACR was 154.6 ± 85.2 mg/g. Macroalbuminuria was present in 30.5% of patients. The frequency of macroalbuminuria increased significantly with higher uric acid levels (p < 0.001). A significant positive correlation was observed between serum uric acid and UACR (r = 0.42, p < 0.001). Stratified analysis showed higher rates of macroalbuminuria among patients with longer diabetes duration and poorer glycemic control. Conclusion: It is concluded that hyperuricemia is significantly associated with increased albuminuria in patients with type 2 diabetes. Monitoring and managing serum uric acid levels may serve as a valuable approach in the early identification and prevention of diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: